Bottom line
BRZU vs METD: the short answer
BRZU (Direxion Daily MSCI Brazil Bull 2X ETF) and METD (Direxion Daily META Bear 1X ETF) are both etfs.
METD is cheaper at 1.02% vs 1.32% — a difference of $30 a year per $10,000 invested.
Over one year, BRZU returned +97.4% vs −17.3% for METD.
Updated Nov 19, 2026
BRZU vs METD side by side
| BRZU | METD | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Direxion | Direxion |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 1.32% | 1.02% |
| Annual cost per $10k | $132 | $102 |
| 10-yr cost on $10k (prospectus) | $1,590 | $1,428 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +97.4% | −17.3% |
| 5-yr return (annualized) | −2.9% | — |
| 10-yr return (annualized) | −12.6% | — |
| Best quarter | +77.2% | +10.1% |
| Worst quarter | −96.0% | −25.5% |
| Net assets (fund) | $105.2M | $10.8M |
| Number of holdings | 8 | 8 |
| Portfolio turnover | % | % |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | BRZU | METD | Difference |
|---|---|---|---|
| 2025 | +97.4% | −17.3% | +114.7% |
Source: Fund prospectus bar charts
Holdings overlap
7 of BRZU's top 8 holdings also appear in METD's top 8.
| Holding | BRZU | METD |
|---|---|---|
| Dreyfus | 45.45% | 67.68% |
| Goldman Financial | 9.90% | 17.87% |
| N/a | 7.53% | 1.07% |
| N/a | 5.09% | 1.07% |
| N/a | 2.33% | 1.07% |
| Goldman Sachs Liq Es Fd A | 0.66% | 12.14% |
| N/a | 0.59% | 1.07% |
Source: SEC Form N-PORT
BRZU top 10
- Ishares MSCI Spain Capped Et — 47.86%
- Dreyfus — 45.45%
- Goldman Financial — 9.90%
- N/a — 7.53%
- N/a — 5.09%
- N/a — 2.33%
- Goldman Sachs Liq Es Fd A — 0.66%
- N/a — 0.59%
METD top 10
- Dreyfus — 67.68%
- Goldman Financial — 17.87%
- Goldman Sachs Liq Es Fd A — 12.14%
- Dreyfus — 3.99%
- N/a — 3.73%
- N/a — 2.57%
- N/a — 2.23%
- N/a — 1.07%
FAQ
What is the difference between BRZU and METD?
Which is cheaper, BRZU or METD?
Should I own both BRZU and METD?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.